Real-time
Oslo Bors
05:12:25 2024-05-22 am EDT
|
5-day change
|
1st Jan Change
|
58.9
NOK
|
-0.51%
|
|
-2.16%
|
-12.61%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,963
|
2,846
|
2,769
|
2,895
|
1,827
|
1,605
|
-
|
-
|
Enterprise Value (EV)
1 |
1,837
|
2,562
|
2,483
|
2,639
|
1,567
|
1,321
|
1,269
|
1,134
|
P/E ratio
|
61.3
x
|
-117
x
|
-89.3
x
|
-40.2
x
|
6,740
x
|
-2,843
x
|
31.3
x
|
13.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.97
x
|
11.1
x
|
7.68
x
|
7.73
x
|
4.09
x
|
3.23
x
|
2.7
x
|
2.27
x
|
EV / Revenue
|
6.53
x
|
9.99
x
|
6.89
x
|
7.05
x
|
3.51
x
|
2.65
x
|
2.13
x
|
1.61
x
|
EV / EBITDA
|
31.2
x
|
-655
x
|
136
x
|
-107
x
|
28.2
x
|
31.6
x
|
11.2
x
|
5.7
x
|
EV / FCF
|
-
|
-16.9
x
|
113
x
|
-469
x
|
35.4
x
|
-377
x
|
21.7
x
|
11.5
x
|
FCF Yield
|
-
|
-5.9%
|
0.89%
|
-0.21%
|
2.82%
|
-0.27%
|
4.61%
|
8.69%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
21,930
|
26,702
|
26,960
|
27,106
|
27,106
|
27,106
|
-
|
-
|
Reference price
2 |
89.50
|
106.6
|
102.7
|
106.8
|
67.40
|
59.20
|
59.20
|
59.20
|
Announcement Date
|
2/27/20
|
3/3/21
|
2/23/22
|
2/23/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
281.6
|
256.5
|
360.5
|
374.5
|
446.2
|
497.5
|
595.4
|
706
|
EBITDA
1 |
58.95
|
-3.912
|
18.3
|
-24.63
|
55.49
|
41.74
|
112.8
|
199
|
EBIT
1 |
42.74
|
-23.2
|
-5.826
|
-49
|
27.81
|
23.09
|
82.14
|
166
|
Operating Margin
|
15.18%
|
-9.05%
|
-1.62%
|
-13.09%
|
6.23%
|
4.64%
|
13.8%
|
23.51%
|
Earnings before Tax (EBT)
1 |
45.9
|
-33.23
|
-31.66
|
-71.13
|
9.738
|
5.211
|
65.14
|
156
|
Net income
1 |
31.83
|
-22.4
|
-30.9
|
-71.86
|
0.267
|
-0.5907
|
51.05
|
122
|
Net margin
|
11.31%
|
-8.73%
|
-8.57%
|
-19.19%
|
0.06%
|
-0.12%
|
8.57%
|
17.28%
|
EPS
2 |
1.460
|
-0.9100
|
-1.150
|
-2.660
|
0.0100
|
-0.0208
|
1.890
|
4.490
|
Free Cash Flow
1 |
-
|
-151.2
|
21.99
|
-5.627
|
44.25
|
-3.5
|
58.5
|
98.5
|
FCF margin
|
-
|
-58.95%
|
6.1%
|
-1.5%
|
9.92%
|
-0.7%
|
9.83%
|
13.95%
|
FCF Conversion (EBITDA)
|
-
|
-
|
120.16%
|
-
|
79.74%
|
-
|
51.87%
|
49.5%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
16,573.78%
|
-
|
114.59%
|
80.74%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
3/3/21
|
2/23/22
|
2/23/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
---|
Net sales
1 |
94.52
|
81.6
|
100.6
|
106.8
|
94.94
|
106.2
|
144.3
|
107.5
|
115
|
118
|
120
|
EBITDA
1 |
-5.469
|
-13.88
|
1.4
|
4.7
|
-16.87
|
-1.2
|
23.39
|
3.339
|
29.92
|
7.9
|
9
|
EBIT
1 |
-11.5
|
-19.88
|
-4.6
|
-1.4
|
-23.1
|
-7.7
|
16.84
|
-3.852
|
22.48
|
0.746
|
23
|
Operating Margin
|
-12.17%
|
-24.36%
|
-4.57%
|
-1.31%
|
-24.33%
|
-7.25%
|
11.67%
|
-3.58%
|
19.54%
|
0.63%
|
19.17%
|
Earnings before Tax (EBT)
1 |
-33.03
|
-27.26
|
-9.053
|
-6.262
|
-28.56
|
-10.1
|
11.96
|
-8.666
|
16.55
|
-4.006
|
18
|
Net income
1 |
-28.15
|
-21.98
|
-18.46
|
-9.932
|
-21.48
|
-11.7
|
4.311
|
-4.788
|
12.48
|
-7.889
|
14
|
Net margin
|
-29.78%
|
-26.94%
|
-18.35%
|
-9.3%
|
-22.63%
|
-11.02%
|
2.99%
|
-4.45%
|
10.85%
|
-6.68%
|
11.67%
|
EPS
|
-1.050
|
-0.8200
|
-0.6800
|
-0.3700
|
-0.7900
|
-0.4300
|
0.1600
|
-0.1800
|
0.4600
|
-0.2900
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/23/22
|
5/11/22
|
8/10/22
|
11/2/22
|
2/23/23
|
5/10/23
|
8/9/23
|
11/8/23
|
2/21/24
|
5/15/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
125
|
285
|
285
|
256
|
260
|
284
|
336
|
471
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-151
|
22
|
-5.63
|
44.3
|
-3.5
|
58.5
|
98.5
|
ROE (net income / shareholders' equity)
|
16.5%
|
-6.25%
|
-6.11%
|
-14.9%
|
0.06%
|
-
|
11.9%
|
26.7%
|
ROA (Net income/ Total Assets)
|
-
|
-4.34%
|
-3.95%
|
-
|
0.04%
|
-
|
-
|
-
|
Assets
1 |
-
|
516.7
|
782.8
|
-
|
715.8
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
167
|
3.7
|
3.61
|
4.06
|
2
|
2.5
|
2.5
|
Capex / Sales
|
-
|
65.03%
|
1.03%
|
0.96%
|
0.91%
|
0.4%
|
0.42%
|
0.35%
|
Announcement Date
|
2/27/20
|
3/3/21
|
2/23/22
|
2/23/23
|
2/21/24
|
-
|
-
|
-
|
Last Close Price
59.2
NOK Average target price
86
NOK Spread / Average Target +45.27% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.61% | 150M | | +37.78% | 723B | | +31.13% | 598B | | -3.51% | 364B | | +19.94% | 331B | | +5.14% | 288B | | +16.51% | 244B | | -4.62% | 208B | | +10.04% | 210B | | +9.32% | 169B |
Other Pharmaceuticals
|